FR2497101A1 - Production d'hormone stimulation de la thyroide humaine - Google Patents

Production d'hormone stimulation de la thyroide humaine Download PDF

Info

Publication number: FR2497101A1
Authority: FR; France
Prior art keywords: human; cells; hsth; line; multiplication
Prior art date: 1980-12-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

FR8124269A

Other languages

English (en)

French (fr)

Other versions

FR2497101B1 (it

Inventor

Kaname Sugimoto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hayashibara Seibutsu Kagaku Kenkyujo KK

Original Assignee

Hayashibara Seibutsu Kagaku Kenkyujo KK

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-12-30

Filing date

1981-12-28

Publication date

1982-07-02

1981-12-28 Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK

1982-07-02 Publication of FR2497101A1 publication Critical patent/FR2497101A1/fr

1984-11-09 Application granted granted Critical

1984-11-09 Publication of FR2497101B1 publication Critical patent/FR2497101B1/fr

Status Granted legal-status Critical Current

Links

238000004519 manufacturing process Methods 0.000 title claims abstract description 33
229940088597 hormone Drugs 0.000 title claims abstract description 18
239000005556 hormone Substances 0.000 title claims abstract description 18
210000001685 thyroid gland Anatomy 0.000 title claims abstract description 4
230000000638 stimulation Effects 0.000 title 1
241001465754 Metazoa Species 0.000 claims abstract description 32
238000000034 method Methods 0.000 claims abstract description 31
230000004936 stimulating effect Effects 0.000 claims abstract description 4
102000011923 Thyrotropin Human genes 0.000 claims abstract description 3
108010061174 Thyrotropin Proteins 0.000 claims abstract description 3
210000004027 cell Anatomy 0.000 claims description 62
210000005260 human cell Anatomy 0.000 claims description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
238000009792 diffusion process Methods 0.000 claims description 8
201000009586 Basophil Adenoma Diseases 0.000 claims description 7
208000020351 pituitary gland basophil adenoma Diseases 0.000 claims description 7
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
210000001124 body fluid Anatomy 0.000 claims description 6
239000010839 body fluid Substances 0.000 claims description 6
208000009339 chromophobe adenoma Diseases 0.000 claims description 6
210000004408 hybridoma Anatomy 0.000 claims description 6
235000015097 nutrients Nutrition 0.000 claims description 6
241000700159 Rattus Species 0.000 claims description 5
230000007910 cell fusion Effects 0.000 claims description 5
238000011580 nude mouse model Methods 0.000 claims description 5
241000699800 Cricetinae Species 0.000 claims description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
239000004472 Lysine Substances 0.000 claims description 3
229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
235000019341 magnesium sulphate Nutrition 0.000 claims description 3
239000011780 sodium chloride Substances 0.000 claims description 3
239000004475 Arginine Substances 0.000 claims description 2
241000283690 Bos taurus Species 0.000 claims description 2
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
241000283707 Capra Species 0.000 claims description 2
241000700199 Cavia porcellus Species 0.000 claims description 2
241000282693 Cercopithecidae Species 0.000 claims description 2
241000272201 Columbiformes Species 0.000 claims description 2
241000283073 Equus caballus Species 0.000 claims description 2
241000282326 Felis catus Species 0.000 claims description 2
241000287828 Gallus gallus Species 0.000 claims description 2
239000004471 Glycine Substances 0.000 claims description 2
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
241000124008 Mammalia Species 0.000 claims description 2
241000699666 Mus <mouse, genus> Species 0.000 claims description 2
241000009328 Perro Species 0.000 claims description 2
241000282898 Sus scrofa Species 0.000 claims description 2
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
239000001110 calcium chloride Substances 0.000 claims description 2
229910001628 calcium chloride Inorganic materials 0.000 claims description 2
235000018417 cysteine Nutrition 0.000 claims description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
229960000874 thyrotropin Drugs 0.000 claims description 2
230000001748 thyrotropin Effects 0.000 claims description 2
102000016605 B-Cell Activating Factor Human genes 0.000 claims 1
108010028006 B-Cell Activating Factor Proteins 0.000 claims 1
201000009030 Carcinoma Diseases 0.000 claims 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
241000018646 Pinus brutia Species 0.000 claims 1
235000011613 Pinus brutia Nutrition 0.000 claims 1
230000001456 gonadotroph Effects 0.000 claims 1
210000004072 lung Anatomy 0.000 claims 1
230000013011 mating Effects 0.000 claims 1
238000000338 in vitro Methods 0.000 abstract description 8
210000004369 blood Anatomy 0.000 abstract description 2
239000008280 blood Substances 0.000 abstract description 2
239000006285 cell suspension Substances 0.000 description 16
206010028980 Neoplasm Diseases 0.000 description 8
241000282412 Homo Species 0.000 description 7
230000036046 immunoreaction Effects 0.000 description 7
238000002360 preparation method Methods 0.000 description 5
238000002054 transplantation Methods 0.000 description 5
230000001413 cellular effect Effects 0.000 description 4
235000013601 eggs Nutrition 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
238000000605 extraction Methods 0.000 description 3
238000003306 harvesting Methods 0.000 description 3
238000005303 weighing Methods 0.000 description 3
206010003445 Ascites Diseases 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
206010062767 Hypophysitis Diseases 0.000 description 2
206010058467 Lung neoplasm malignant Diseases 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
241000700605 Viruses Species 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
201000005296 lung carcinoma Diseases 0.000 description 2
239000012528 membrane Substances 0.000 description 2
230000000050 nutritive effect Effects 0.000 description 2
210000003635 pituitary gland Anatomy 0.000 description 2
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
208000003200 Adenoma Diseases 0.000 description 1
206010001233 Adenoma benign Diseases 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
241000272814 Anser sp. Species 0.000 description 1
101100016204 Butyrivibrio fibrisolvens ced1 gene Proteins 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
235000019766 L-Lysine Nutrition 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
229930064664 L-arginine Natural products 0.000 description 1
235000014852 L-arginine Nutrition 0.000 description 1
XNSAINXGIQZQOO-UHFFFAOYSA-N L-pyroglutamyl-L-histidyl-L-proline amide Natural products NC(=O)C1CCCN1C(=O)C(NC(=O)C1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-UHFFFAOYSA-N 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
241000215040 Neso Species 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
235000010676 Ocimum basilicum Nutrition 0.000 description 1
240000007926 Ocimum gratissimum Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
102100032251 Pro-thyrotropin-releasing hormone Human genes 0.000 description 1
101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 1
101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
235000009697 arginine Nutrition 0.000 description 1
210000003651 basophil Anatomy 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000012136 culture method Methods 0.000 description 1
238000003795 desorption Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
229940084986 human chorionic gonadotropin Drugs 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000002513 implantation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
238000009776 industrial production Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
244000144977 poultry Species 0.000 description 1
XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
235000015424 sodium Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
101150035983 str1 gene Proteins 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
229940034199 thyrotropin-releasing hormone Drugs 0.000 description 1
210000003371 toe Anatomy 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
General Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Epidemiology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FR8124269A 1980-12-30 1981-12-28 Production d'hormone stimulation de la thyroide humaine Granted FR2497101A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP55187010A JPS5826317B2 (ja)	1980-12-30	1980-12-30	ヒト甲状腺刺激ホルモンの製造方法

Publications (2)

Publication Number	Publication Date
FR2497101A1 true FR2497101A1 (fr)	1982-07-02
FR2497101B1 FR2497101B1 (it)	1984-11-09

Family

ID=16198616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR8124269A Granted FR2497101A1 (fr)	1980-12-30	1981-12-28	Production d'hormone stimulation de la thyroide humaine

Country Status (6)

Country	Link
JP (1)	JPS5826317B2 (it)
KR (1)	KR860001589B1 (it)
CH (1)	CH652747A5 (it)
FR (1)	FR2497101A1 (it)
GB (1)	GB2092156B (it)
IT (1)	IT1148019B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS609795B2 (ja) *	1980-12-11	1985-03-13	株式会社林原生物化学研究所	ヒト上皮細胞成長因子の製造方法
GB9015327D0 (en) *	1990-07-12	1990-08-29	Tan Kim S	Hybridomas
KR101789509B1 (ko) *	2015-11-05	2017-10-26	주식회사 프로젠	재조합 인간 갑상선 자극 호르몬을 포함하는 조성물 및 상기 재조합 인간 갑상선 자극 호르몬의 생산 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2414920A1 (fr) *	1978-01-22	1979-08-17	Hayashibara Ken	Interferon et preparation le contenant
FR2446637A1 (fr) *	1979-01-18	1980-08-14	Hayashibara Ken	Procede pour preparer de l'interferon de type ii et preparations contenant de l'interferon de type ii

1980
- 1980-12-30 JP JP55187010A patent/JPS5826317B2/ja not_active Expired
1981
- 1981-12-21 CH CH8155/81A patent/CH652747A5/fr not_active IP Right Cessation
- 1981-12-22 IT IT49978/81A patent/IT1148019B/it active
- 1981-12-22 GB GB8138587A patent/GB2092156B/en not_active Expired
- 1981-12-23 KR KR1019810005089A patent/KR860001589B1/ko active
- 1981-12-28 FR FR8124269A patent/FR2497101A1/fr active Granted

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2414920A1 (fr) *	1978-01-22	1979-08-17	Hayashibara Ken	Interferon et preparation le contenant
FR2446637A1 (fr) *	1979-01-18	1980-08-14	Hayashibara Ken	Procede pour preparer de l'interferon de type ii et preparations contenant de l'interferon de type ii

Also Published As

Publication number	Publication date
CH652747A5 (fr)	1985-11-29
KR860001589B1 (ko)	1986-10-13
JPS5826317B2 (ja)	1983-06-02
GB2092156A (en)	1982-08-11
GB2092156B (en)	1984-05-10
JPS57115180A (en)	1982-07-17
IT1148019B (it)	1986-11-26
FR2497101B1 (it)	1984-11-09
IT8149978A0 (it)	1981-12-22
KR830007087A (ko)	1983-10-14

Legal Events

Date	Code	Title	Description
1992-10-30	ST	Notification of lapse

Publication	Publication Date	Title
FR2488803A1 (fr)	1982-02-26	Procede pour la production d'erythropoietine humaine
FR2495937A1 (fr)	1982-06-18	Procede pour la production du facteur de croissance epidermique humain
FR2497099A1 (fr)	1982-07-02	Production de facteur leucopoietique humain
FR2489152A1 (fr)	1982-03-05	Production d'hormone humaine stimulant les follicules
FR2489151A1 (fr)	1982-03-05	Production d'hormone luteinisante humaine
FR2495635A1 (fr)	1982-06-11	Production d'urokinase humaine
FR2488805A1 (fr)	1982-02-26	Procede pour la production de gonadotrophine chorionique humaine
FR2487851A1 (fr)	1982-02-05	Procede pour la production d'insuline humaine
FR2556220A1 (fr)	1985-06-14	Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leur production et leurs utilisations
FR2497101A1 (fr)	1982-07-02	Production d'hormone stimulation de la thyroide humaine
FR2487852A1 (fr)	1982-02-05	Production d'hormone de croissance humaine
CH652748A5 (fr)	1985-11-29	Production d'hormone parathyroidienne humaine.
CH652749A5 (fr)	1985-11-29	Production de calcitonine humaine.
FR2497103A1 (fr)	1982-07-02	Production de facteur de croissance humain
FR2496466A1 (fr)	1982-06-25	Production d'hormone lactogene, placentaire, humaine
FR2572936A1 (fr)	1986-05-16	Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations
FR2488804A1 (fr)	1982-02-26	Procede pour la production de prolactine humaine
JPS6350992B2 (it)	1988-10-12
FR2521588A1 (fr)	1983-08-19	Procede de production de suppresseur de reponse immunitaire humain
CH652745A5 (fr)	1985-11-29	Procede pour la production d'hormone adrenocorticotrope humaine.
CH658668A5 (fr)	1986-11-28	Procede pour la production de kallikreine humaine.
FR2523155A1 (fr)	1983-09-16	Preparation de facteur de croissance des cellules t humaines
CH651588A5 (en)	1985-09-30	Preparation of human T cell growth factor